PRDM13
protein-codingPR/SET domain 13, the group of PR/SET domain family
Gene summary
Predicted to enable histone methyltransferase activity. Predicted to be involved in regulation of gene expression. Predicted to act upstream of or within negative regulation of transcription by RNA polymerase II and neurogenesis. Predicted to be active in nucleus. Implicated in pontocerebellar hypoplasia. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007630
Submitter: Franklin by Genoox
Two presumed unrelated families with North Carolina macular dystrophy (NCMD) were found to carry a a novel duplication in PRDM13 gene
Inheritance Pattern: AD
Disease ID:MONDO:0007630
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0030890
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0859229
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0010932
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007630
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0030890
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0859229
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0859229
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Neurologic; Ophthalmologic
Intervention: Endocrine
Rationale: Individuals may have hypogonadotropic hypogonadism, and surveillance in adolescence related to sexual maturation is indicated, as is monitoring of bone mineral density in order to allow early detection and treatment of disease
Comments: Macular dystrophy, retinal, 3 is caused by heterozygous tandem duplication of a cis-regulatory element region downstream of IRX1, which affects IRX1 and PRDM13 activity
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PRDM13 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021620.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 186 | 4 | 192 | ||
| missense | 361 | 33 | 2 | 396 | ||
| nonsense | 2 | 3 | 5 | |||
| start loss | 1 | 1 | ||||
| frameshift | 3 | 2 | 9 | 14 | ||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 4 | 4 | 378 | 219 | 6 | 611 |
Highest pathogenic variant AF is 0.000005477794
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_067633.2 | 4 | MANE Select | |
| Ensembl | ENSP00000358217.5 | 4 | MANE Select | |
| Ensembl | ENSP00000358216.2 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of transcription by RNA polymerase II
- histone methylation
- neurogenesis
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- chromatin DNA binding
- histone methyltransferase activity
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000369215
- Coding exons
- 4
- Length
- 8849
- Individuals with no LoFs
- 124763
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 14
- Defined
- 124777
- p
- 0.0000561
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.423 | 353 | 376 | 0.939 | 0.0000173 | 4424 |
| Missense (PolyPhen) | 95 | 124.7 | 0.76183 | 1434 | ||
| Synonymous | -1.04 | 187 | 170 | 1.10 | 0.00000840 | 1560 |
| Loss of Function | 3.30 | 4 | 19.9 | 0.201 | 8.55e-7 | 239 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00018 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000093 | 0.000093 | rare |
| European (Non-Finnish) | 0.000047 | 0.000044 | rare |
| South Asian | 0.000034 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in transcriptional regulation.;
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.843
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |